[Renal effects of the acute inhibition of angiotensin-converting enzyme. I. 2) Studies during moderate potassium depletion].
We have investigated the relative roles of angiotensin II on the renal function and urinary excretion of some prostanoids in healthy women submitted to different conditions of potassium balance. To this aim we have evaluated the effects of an acute inhibition of angiotensin converting enzyme by enalapril (E). The renal function was explored by clearance (cl.) method during induced hypotonic polyuria (oral water load followed by 5% dextrose solution infusion). During 60 min cl. period the urinary PGE2, 6-keto-PGF1 alpha and TxB2 were determined by RIA method. Each subject received paired studies, in absence and presence of E (10 mg administered per os 1 hour before the water load). Basal values of plasma renin activity (PRA) and urinary aldosterone (excreted during the 24 hours before the water load) were also determined by RIA method. This study protocol was applied in normal potassium balance (n = 6) and induced moderate potassium depletion (n = 6). This paper concerns the group in potassium depletion in both absence (D4) and presence of E (D4.E). Potassium depletion was induced by adaptation to a normal sodium (150 mmol/d) and low potassium (< or = 10 mmol/d) dietary intake combined to natriuretic treatment. The water and NaCl net losses were restored by 0.9% NaCl solution infusion. The cumulative potassium deficit achieved at the end of the depletive treatment was 214 +/- 54 mmol. This treatment induced significant decrease in basal plasma potassium concentration and increase in PRA without affecting urinary aldosterone and plasma sodium concentration.(ABSTRACT TRUNCATED AT 250 WORDS)
Agnoli
G C
GC
Cattedra di Medicina Interna I, Università di Bologna.
Borgatti
R
R
Cacciari
M
M
Ikonomu
E
E
Lenzi
P
P
Marinelli
M
M
Martello
M
M
D000450:Aldosterone / Q000097:blood; D000804:Angiotensin II / Q000502:physiology*; D001794:Blood Pressure / Q000187:drug effects; D002712:Chlorides / Q000652:urine; D004656:Enalapril / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D009318:Natriuresis / Q000187:drug effects; D011191:Potassium Deficiency / Q000503:physiopathology*; D017419:Potassium, Dietary / Q000008:administration & dosage; D011453:Prostaglandins / Q000652:urine; D012083:Renin / Q000097:blood; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage; D014883:Water-Electrolyte Imbalance / Q000503:physiopathology*
D002712:Chlorides; D017419:Potassium, Dietary; D011453:Prostaglandins; D012462:Saline Solution, Hypertonic; D000804:Angiotensin II; D000450:Aldosterone; D004656:Enalapril; D012083:Renin
Effetti renali della inibizione acuta dell'enzima convertente l'angiotensina. I. 2). Studi in moderata deplezione potassica.